PS-052-End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection

Ohad Etzion, Saeed Hamid, Yoav Lurie, Edward Gane, Nimrah Bader, David Yardeni, Anat Nevo-Shor, sm channa, Minaz Mawani, Om Parkash, Kyunghee Yang, Diane Longo, Robert G. Gish, Jeffrey S. Glenn, David Apelian

Journal of Hepatology

April 1, 2019

10.1016/s0618-8278(19)30058-1

Cited by 53

Abstract

Related Papers

No related papers found

Powered by citation graph analysis